MRNA
Moderna, Inc. · Healthcare · Biotechnology
TECHBuyZACKSHold
R500#197 today
$190.01
+0.57% today · -4.46% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- MRNA +0.57% on the last session vs SPY +0.74%: −0.2 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 59 big drops in the past 5 years, MRNA typically lost 3.5% over the next week (median) and was higher only 36% of the time; half the outcomes fell between -8.2% and +7.4%. An ordinary week: -0.3%. Among S&P 500 stocks after big drops, that ranks #466 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
MRNA against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #197 | +0.57% | +0.74% | |
| 1 week | #449 | -4.46% | -0.22% | |
| 1 month | #11 | +25.99% | +0.84% | |
| 3 months | #1 | +138.23% | +3.59% | |
| 6 months | #1 | +286.20% | +17.95% | |
| 1 year | #2 | +569.76% | +16.25% | |
| Overall | #51 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Biotechnology
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | -0.34 | #473 | #5 |
| fPE/tPE | #1 | #1 | |
| PE/G | #1 | #1 | |
| EV/Revenue | 32.32 | #3 | #1 |
| Gross Margin | -0.66 | #482 | #5 |
| Profit Margin | -1.41 | #476 | #5 |
| Revenue Growth | 0.02 | #416 | #4 |